Atai Life Sciences Announces Leadership Transition

New York and Berlin, May 15, 2024 (Globe Newswire) -- Atai Life Sciences, a clinical-stage biopharmaceutical company, has unveiled its first quarter 2024 financial results and shared corporate updates. Notably, Co-Founder Florian Brand will step down as CEO in a planned transition by the end of 2024. He will be succeeded by Co-Founder and current Chief Scientific Officer, Srinivas Rao, M.D., Ph.D..

Read full article here.